SGS SA (SGSN):企業の財務・戦略的SWOT分析

◆英語タイトル:SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDBCS26536FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

SGS SA (SGSN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SGS SA (SGS) is a provider of inspection, verification, testing, certification, and quality assurance services. The company also provides risk management, consultancy, sustainability solutions, and training services. SGS inspects, samples, analyses, and monitors raw materials, components, and products for compliance with industrial standards and local regulatory requirements, including tax and duty. The company serves various industries including chemical, oil and gas, agriculture and food, construction, energy, life sciences, arts and culture, mining, public sector, logistics, industrial manufacturing, consumer goods and retail, environment, and transportation. It operates through a network of offices and laboratories in Europe, Africa, the Middle East, the Americas, and the Asia Pacific. SGS is headquartered in Geneva, Switzerland.

SGS SA Key Recent Developments

Apr 22,2021: Yvonne Tse Appointed Vice President – Global Softlines
Mar 24,2021: SGS nominated for Best Contract Research Organization at the ViE Awards
Feb 17,2021: Procredit Bank Bulgaria achieves edge zero carbon certification with SGS and Sintali
Feb 05,2021: Tema LNG selects SGS to inspect their new floating regasification unit (FRU) in Shanghai
Jan 14,2021: Corpus Christi lab was recently awarded accreditation ISO 17025

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
SGS SA – Key Facts
SGS SA – Key Employees
SGS SA – Key Employee Biographies
SGS SA – Major Products and Services
SGS SA – History
SGS SA – Company Statement
SGS SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
SGS SA – Business Description
Business Segment: Agriculture, Food and Life
Overview
Performance
Business Segment: Certification and Business Enhancement
Overview
Performance
Business Segment: Consumer and Retail
Overview
Performance
Business Segment: Environment, Health and Safety
Overview
Performance
Business Segment: Governments and Institutions
Overview
Performance
Business Segment: Industrial
Overview
Performance
Business Segment: Minerals
Overview
Performance
Business Segment: Oil, Gas and Chemicals
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe/Africa/Middle East
Performance
SGS SA – Corporate Strategy
SGS SA – SWOT Analysis
SWOT Analysis – Overview
SGS SA – Strengths
SGS SA – Weaknesses
SGS SA – Opportunities
SGS SA – Threats
SGS SA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
SGS SA, Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 22, 2021: Yvonne Tse Appointed Vice President – Global Softlines
Mar 24, 2021: SGS nominated for Best Contract Research Organization at the ViE Awards
Feb 17, 2021: Procredit Bank Bulgaria achieves edge zero carbon certification with SGS and Sintali
Feb 05, 2021: Tema LNG selects SGS to inspect their new floating regasification unit (FRU) in Shanghai
Jan 14, 2021: Corpus Christi lab was recently awarded accreditation ISO 17025
Nov 19, 2020: SGS’S sustainability performance receives strong rating in DJSI world and europe for 2020
Nov 10, 2020: SGS completes investment and expansion in new testing laboratories in Glasgow, UK
Oct 12, 2020: SGS wins highly commended award in the 2020 vaccine industry excellence awards
Sep 28, 2020: Mexus announces update on activities at Santa Elena project
Aug 21, 2020: SGS and OPECS partner to offer SGS Arpin workflow and consultancy
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
SGS SA, Key Facts
SGS SA, Key Employees
SGS SA, Key Employee Biographies
SGS SA, Major Products and Services
SGS SA, History
SGS SA, Subsidiaries
SGS SA, Key Competitors
SGS SA, Ratios based on current share price
SGS SA, Annual Ratios
SGS SA, Annual Ratios (Cont...1)
SGS SA, Annual Ratios (Cont...2)
SGS SA, Interim Ratios
SGS SA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[SGS SA (SGSN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xbrane Biopharma AB (XBRANE):企業の財務・戦略的SWOT分析
    Summary Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products . The company's product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It comb …
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • GrafTech International Ltd:企業の戦略・SWOT・財務情報
    GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report Summary GrafTech International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • Ei Towers SpA:企業の戦略・SWOT・財務分析
    Ei Towers SpA - Strategy, SWOT and Corporate Finance Report Summary Ei Towers SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • L3 Technologies Inc (LLL):企業の戦略的SWOT分析
    L3 Technologies Inc (LLL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Chart Industries Inc (GTLS):企業の財務・戦略的SWOT分析
    Chart Industries Inc (GTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tenaska Inc:電力:M&Aディール及び事業提携情報
    Summary Tenaska Inc (Tenaska) is an independent power development and energy marketing company. It develops, designs, finances, and manages and operates power plants. The company purchases and sells natural gas, electric capacity, energy, and renewable energy products; acquires, manages, and optimiz …
  • Approach Resources Inc (AREXQ):企業の財務・戦略的SWOT分析
    Approach Resources Inc (AREXQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • KineMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary KineMed Inc (KineMed) is a biotechnology company that develops and commercializes proprietary biomarker platform technology. The company applies its proprietary biomarker platform technology to drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs …
  • Windtree Therapeutics Inc (WINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead developme …
  • Genetic Technologies Ltd (GTG):企業の財務・戦略的SWOT分析
    Genetic Technologies Ltd (GTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • University of Massachusetts Medical School:企業のM&A・事業提携・投資動向
    University of Massachusetts Medical School - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Massachusetts Medical School Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • WESCO International, Inc.:企業の戦略・SWOT・財務分析
    WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report Summary WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • NantKwest Inc (NK):企業の財務・戦略的SWOT分析
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Softrock Minerals Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Softrock Minerals Ltd (Softrock Minerals), formerly Petromax Resources Inc is an oil and gas exploration and development company. The company acquires, explores and develops oil and gas, and mineral deposits. It holds oil and gas producing interests in Alberta. Softrock Minerals also holds m …
  • iBio Inc (IBIO)-製薬・医療分野:企業M&A・提携分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, …
  • FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • Recipharm AB:企業のM&A・事業提携・投資動向
    Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆